Study of PEG-Intron for Plexiform Neurofibromas

NCT00396019 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Plexiform Neurofibroma

Interventions

DRUG: PEG-Intron

Sponsor

University of Pittsburgh

Collaborators

[object Object]